19.11.2019 • NewsDede WillamsPerstorp

Perstorp Building new Penta Plant in India

Perstorp Building new Penta Plant in India (c) Perstorp
Perstorp Building new Penta Plant in India (c) Perstorp

Swedish specialty chemical company Perstorp plans to build a new plant in India’s Gujarat state to produce Pentaerythritol (Penta). The world-scale, greenfield facility’s output will include the renewable grades of its branded Voxtar, claimed to provide up to a 60% reduced carbon footprint.

Construction began in October, with groundbreaking celebrated in early November. Commercial production is due to start in Q1 2022, and when fully operational the site will employ 120 people. 

Penta is an essential building block for coatings and is also is used by the synthetic lubricants and antioxidants industry.

Production capacity was not disclosed, but CEO Jan Secher said the new investment would “significantly expand” the company’s Penta production output to 40,000 t/y from 2022 onward.

Perstorp currently produces Penta in Germany, the US and Sweden. Secher pointed to India as a strategic market with a growing demand for coatings, where the company has been planning to deepen its footprint for several years. 

In February 2016, the Swedish producer, which regards itself as the global leader in Penta, signed a Memorandum of Understanding with Maharashtra Industrial Development Corporation (MIDC) to explore opportunities in India.

Secher said the Gujarat investment will reinforce Perstorp’s ability to meet in particular increasing demand from Asian markets as well allowing it to offer Penta derivatives such as Penta Mono, Di-Penta and Calcium Formate.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.